Your search returned 15 results. Subscribe to this search

|
1. Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors. [Review]

by Barac, Ana.

Published: 2021; ; ; Citation: Circulation Research. 128(12):1973-1987, 2021 06 11.; .Institution: MedStar Heart & Vascular Institute.Publication: Journal Article.Article type: Journal Article.Full author list: Barac A; Beckman JA; Fleming MR; Jackson KD; Moslehi JJ; Xiao L.UI/PMID: 34110908.Digital Object Identifier: https://dx.doi.org/10.1161/CIRCRESAHA.121.318259 (Click here)
2. Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies. [Review]

by Agunbiade, Tolulope A; Barac, Ana; Zaghlol, Raja.

Published: ; 2019; Citation: ; Methodist DeBakey cardiovascular journal. 15(4):250-257, 2019 Oct-Dec..Institution: MedStar Heart & Vascular Institutena; MedStar Union Memorial Hospital; MedStar Washington Hospital Center.Department: Cardio-Oncology; Medicine/Internal Medicine.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Agunbiade TA; Barac A; Zaghlol RY.UI/PMID: 31988685.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.14797/mdcj-15-4-250 (Click here)
3. Salutary Response to Targeted Therapy in Anaplastic Thyroid Cancer

by Burman, Kenneth D.

Published: ; 2019; Citation: ; Journal of Investigative Medicine High Impact Case Reports. 7:2324709619890942, 2019 Jan-Dec..Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology.Publication: Journal Article.Article type: Journal Article.Full author list: Burman KD; Fazeli S; Khosla SG; Maxwell JH; Nylen ES; Paal E.UI/PMID: 31766881.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1177/2324709619890942 (Click here)
4. Report from Session III of the Second International Colloquium on Cardio-oncology: Cardio-oncological management of patients. [Review]

by Barac, Ana.

Published: 2019; ; Citation: Seminars in Oncology. 46(6):408-413, 2019 12.; .Institution: MedStar Heart & Vascular Institute.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Barac A; Cardinale DM; Khandheria BK; Lenihan D; Minotti G; Torbicki A.UI/PMID: 31784042.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1053/j.seminoncol.2019.11.002 (Click here)
5. Role of Anti-EGFR Targeted Therapies in Stage III Locally Advanced Non-small Cell Lung Cancer: Give or Not to Give?. [Review]

by Desai, Sanjal; Kim, Chul; Veytsman, Irina.

Published: ; 2019; Citation: ; Current Oncology Reports. 21(9):84, 2019 08 13..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Desai S; Kim C; Veytsman I.UI/PMID: 31410582.Digital Object Identifier: https://dx.doi.org/10.1007/s11912-019-0835-x (Click here)
6. A case of checkpoint inhibitor-induced celiac disease

by Alsaadi, Dana.

Published: ; 2019; Citation: ; Journal for Immunotherapy of Cancer. 7(1):203, 2019 08 05..Institution: MedStar Washington Hospital Center.Department: Medicine/Internal Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Alsaadi D; Atkins MB; Charabaty A; Shah NJ.UI/PMID: 31383006.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1186/s40425-019-0694-x (Click here)
7. Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study

by Asch, Federico M; Barac, Ana; Cunningham, A; Gallagher, Christopher; Hofmeyer, Mark; Srichai, M B; Swain, Sandra M.

Published: 2019; Citation: Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun..Institution: MedStar Health ; MedStar Health Research Institute; MedStar Heart & Vascular Institute; Washington Cancer Institute.Department: Associate Dean for Research Development.Publication: Journal Article.Article type: Journal Article.Full author list: Asch FM; Barac A; Cunningham A; Dang C; Gallagher C; Geng X; Herbolsheimer P; Hofmeyer M; Isaacs C; Lynce F; Nunes R; Pohlmann PR; Shajahan-Haq A; Smith KL; Srichai MB; Swain SM; Tan MT; Timothee P; Warren R; Yu AF.UI/PMID: 30852761.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1007/s10549-019-05191-2 (Click here)
8. Radioiodine refractory differentiated thyroid cancer. [Review]

by Van Nostrand, Douglas.

Published: 2018Citation: Critical Reviews in Oncology-Hematology. 125:111-120, 2018 May..Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Jin Y; Van Nostrand D; Cheng L; Liu M; Chen L.UI/PMID: 29650270.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.critrevonc.2018.03.012 (Click here)
9. Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease

by Epstein, Stephen E.

Published: 2017Citation: Nature Genetics. 49(10):1450-1457, 2017 Oct.Institution: MedStar Health Research Institute.Publication: Journal Article.Article type: Journal Article.Full author list: Zhao W; Rasheed A; Tikkanen E; Lee JJ; Butterworth AS; Howson JMM; Assimes TL; Chowdhury R; Orho-Melander M; Damrauer S; Small A; Asma S; Imamura M; Yamauch T; Chambers JC; Chen P; Sapkota BR; Shah N; Jabeen S; Surendran P; Lu Y; Zhang W; Imran A; Abbas S; Majeed F; Trindade K; Qamar N; Mallick NH; Yaqoob Z; Saghir T; Rizvi SNH; Memon A; Rasheed SZ; Memon FU; Mehmood K; Ahmed N; Qureshi IH; Tanveer-Us-Salam; Iqbal W; Malik U; Mehra N; Kuo JZ; Sheu WH; Guo X; Hsiung CA; Juang JJ; Taylor KD; Hung YJ; Lee WJ; Quertermous T; Lee IT; Hsu CC; Bottinger EP; Ralhan S; Teo YY; Wang TD; Alam DS; Di Angelantonio E; Epstein S; Nielsen SF; Nordestgaard BG; Tybjaerg-Hansen A; Young R; CHD Exome+ Consortium; Benn M; Frikke-Schmidt R; Kamstrup PR; EPIC-CVD Consortium; EPIC-Interact Consortium; Michigan Biobank; Jukema JW; Sattar N; Smit R; Chung RH; Liang KW; Anand S; Sanghera DK; Ripatti S; Loos RJF; Kooner JS; Tai ES; Rotter JI; Chen YI; Frossard P; Maeda S; Kadowaki T; Reilly M; Pare G; Melander O; Salomaa V; Rader DJ; Danesh J; Voight BF; Saleheen D.UI/PMID: 28869590.Digital Object Identifier: https://dx.doi.org/10.1038/ng.3943 (Click here)
10. Targeted Therapies in Combination With Immune Therapies for the Treatment of Metastatic Melanoma

by Khan, Shaheer.

Published: 2017Citation: Cancer Journal. 23(1):59-62, 2017 Jan/Feb.Institution: MedStar Washington Hospital Center.Department: Medicine.Publication: Journal Article.Article type: Journal Article.Full author list: Christiansen SA; Khan S; Gibney GT.UI/PMID: 28114256.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1097/PPO.0000000000000245 (Click here)
11. SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function

by Lynce, Filipa; Barac, Ana; Asch, Federico M; Swain, Sandra M.

Published: 2017Citation: Oncologist. 22(5):518-525, 2017 May.Institution: Washington Cancer Institute; MedStar Heart & Vascular Institute.Publication: Journal Article.Article type: Journal Article.Full author list: Lynce F; Barac A; Tan MT; Asch FM; Smith KL; Dang C; Isaacs C; Swain SM.UI/PMID: 28314836.Digital Object Identifier: https://dx.doi.org/10.1634/theoncologist.2016-0412 (Click here)
12. Kinase inhibitors and monoclonal antibodies in oncology: clinical implications. [Review]

by Groninger, Hunter.

Published: 2016Citation: Nature Reviews Clinical Oncology. 13(4):209-27, 2016 Apr..Institution: MedStar Washington Hospital Center.Department: Medicine/Palliative Care.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Gharwan H; Groninger H.UI/PMID: 26718105.Digital Object Identifier: http://dx.doi.org/10.1038/nrclinonc.2015.213 (Click here)
13. Glucose-deprivation increases thyroid cancer cells sensitivity to metformin

by Bikas, Athanasios; Klubo-Gwiezdzinska, Joanna; Burman, Kenneth D; Wartofsky, Leonard.

Published: 2015Citation: Endocrine-Related Cancer. 22(6):919-32, 2015 Dec..Institution: MedStar Washington Hospital Center.Department: Medicine/Endocrinology.Publication: Journal Article.Article type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S..Full author list: Bikas A; Jensen K; Patel A; Costello J Jr; McDaniel D; Klubo-Gwiezdzinska J; Larin O; Hoperia V; Burman KD; Boyle L; Wartofsky L; Vasko V.UI/PMID: 26362676.Digital Object Identifier: http://dx.doi.org/10.1530/ERC-15-0402 (Click here)
14. Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial

by Swain, Sandra M.

Citation: Lancet Oncology. 14(12):1183-92, 2013 Nov..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't.Full author list: Robidoux A; Tang G; Rastogi P; Geyer CE Jr; Azar CA; Atkins JN; Fehrenbacher L; Bear HD; Baez-Diaz L; Sarwar S; Margolese RG; Farrar WB; Brufsky AM; Shibata HR; Bandos H; Paik S; Costantino JP; Swain SM; Mamounas EP; Wolmark N.UI/PMID: 24095300.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1016/S1470-2045(13)70411-X (Click here)
15. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study

by Swain, Sandra M.

Published: 2013Citation: Lancet Oncology. 14(6):461-71, 2013 May..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't.Full author list: Baselga J; Benyunes MC; Campone M; Ciruelos E; Clark E; Cortes J; Ferrero JM; Kim SB; Knott A; Ro J; Ross G; Schneeweiss A; Semiglazov V; Swain SM.UI/PMID: 23602601.Online Access: Click here to access online Digital Object Identifier: (Click here)

Powered by Koha